Annamalai, Lakshmanan

Merck & Co., Inc., Rahway, NJ, USA (United States)

2 papers on CoChat

Most cited papers

Verified
PD-1 Blockade with pembrolizumab in advanced Merkel-cell carcinoma
Nghiem, P. T., Bhatia, S., Lipson, E. J., Kudchadkar, R. R., Miller, N. J., Annamalai, L., Berry, S., Chartash, E. K., Daud, A., Fling, S. P., et al. (2016) · New England Journal of Medicine
Polyomavirus and related diseasesCancer Immunotherapy and Biomarkers
Cited by 1,258
Verified
LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis
Bauché, D., Joyce-Shaikh, B., Jain, R., Grein, J., Ku, K. S., Blumenschein, W. M., Ganal-Vonarburg, S. C., Wilson, D. C., McClanahan, T. K., Malefyt, R. D. W., et al. (2018) · Immunity
IL-33, ST2, and ILC PathwaysT-cell and B-cell Immunology
Cited by 202

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free